Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Frontiers in Pharmacology|July 19, 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19Mario Karolyi, Sara Omid, Erich Pawelka, et al.Journal of the American College of Cardiology|December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trialEva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.Translational Psychiatry|February 3, 2026
Acute effects of selective serotonin reuptake inhibitors on cerebral glucose metabolism and blood flowLeo R Silberbauer, Murray B Reed, Gregor Gryglewski, et al.Thrombosis and Haemostasis|July 11, 2017
Prasugrel in critically ill patientsChristian Schoergenhofer, Eva-Luise Hobl, Thomas Staudinger, et al.Journal of Hepatology|May 23, 2022
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver diseaseKatharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, et al.European Journal of Clinical Investigation|May 31, 2017
Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trialChristian Schoergenhofer, Eva-Luise Hobl, Michael Schwameis, et al.The EPMA Journal|February 24, 2025
Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in AustriaMichael Bolliger, Daniel Wasinger, Julia Brunmair, et al.Clinical Pharmacology and Therapeutics|September 16, 2017
Clopidogrel in Critically Ill PatientsChristian Schoergenhofer, Eva-Luise Hobl, Peter Schellongowski, et al.Therapeutic Advances in Psychopharmacology|November 24, 2022
Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humansThomas Vanicek, Murray B Reed, René Seiger, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 21, 2021
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolismJakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer, et al.Pageof 8